Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.

Literature DB >> 23765226

Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.

I Gómez-Seguí, H Makishima, A Jerez, K Yoshida, B Przychodzen, S Miyano, Y Shiraishi, H D Husseinzadeh, K Guinta, M Clemente, N Hosono, M A McDevitt, A R Moliterno, M A Sekeres, S Ogawa, J P Maciejewski.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2013 PMID： 23765226 PMCID： PMC8711127 DOI： 10.1038/leu.2013.179

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

14 in total

1. Biochemical characterization of the Ras-related GTPases Rit and Rin.

Authors: H Shao; K Kadono-Okuda; B S Finlin; D A Andres
Journal: Arch Biochem Biophys Date: 1999-11-15 Impact factor: 4.013

2. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].

Authors: Jin-Tian Li; Wei Liu; Zhi-He Kuang; Han-Kui Chen; Da-Jiang Li; Qi-Sheng Feng; Qi-Cai Liu; Bin Hu
Journal: Ai Zheng Date: 2003-07

3. Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.

Authors: F Dicker; C Haferlach; J Sundermann; N Wendland; T Weiss; W Kern; T Haferlach; S Schnittger
Journal: Leukemia Date: 2010-06-03 Impact factor: 11.528

4. A rit GTPase-p38 mitogen-activated protein kinase survival pathway confers resistance to cellular stress.

Authors: Geng-Xian Shi; Ling Jin; Douglas A Andres
Journal: Mol Cell Biol Date: 2011-03-28 Impact factor: 4.272

Review 5. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors: C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal: Blood Date: 1997-05-15 Impact factor: 22.113

6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.

Authors: E V Rusyn; E R Reynolds; H Shao; T M Grana; T O Chan; D A Andres; A D Cox
Journal: Oncogene Date: 2000-09-28 Impact factor: 9.867

7. Karyotypic abnormalities in myelofibrosis following polycythemia vera.

Authors: Joris Andrieux; Jean Loup Demory; Marie Thérèse Caulier; Philippe Agape; Marc Wetterwald; Francis Bauters; Jean Luc Laï
Journal: Cancer Genet Cytogenet Date: 2003-01-15

8. [Mutation and amplification of RIT1 gene in hepatocellular carcinoma].

Authors: Jin-tian Li; Wei Liu; Zhi-he Kuang; Ru-hua Zhang; Han-kui Chen; Qi-sheng Feng
Journal: Zhonghua Yi Xue Yi Chuan Xue Za Zhi Date: 2004-02

9. Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS.

Authors: Tapan M Kadia; Hagop Kantarjian; Steven Kornblau; Gautam Borthakur; Stefan Faderl; Emil J Freireich; Raja Luthra; Guillermo Garcia-Manero; Sherry Pierce; Jorge Cortes; Farhad Ravandi
Journal: Cancer Date: 2012-05-08 Impact factor: 6.860

10. An evolutionarily conserved Rit GTPase-p38 MAPK signaling pathway mediates oxidative stress resistance.

Authors: Weikang Cai; Jennifer L Rudolph; Susan M W Harrison; Ling Jin; Aubrey L Frantz; Douglas A Harrison; Douglas A Andres
Journal: Mol Biol Cell Date: 2011-07-07 Impact factor: 4.138

30 in total

1. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Authors: Masako Yaoita; Tetsuya Niihori; Seiji Mizuno; Nobuhiko Okamoto; Shion Hayashi; Atsushi Watanabe; Masato Yokozawa; Hiroshi Suzumura; Akihiko Nakahara; Yusuke Nakano; Tatsunori Hokosaki; Ayumi Ohmori; Hirofumi Sawada; Ohsuke Migita; Aya Mima; Pablo Lapunzina; Fernando Santos-Simarro; Sixto García-Miñaúr; Tsutomu Ogata; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Shigeo Kure; Yoko Aoki
Journal: Hum Genet Date: 2015-12-29 Impact factor: 4.132

Review 2. Somatic SETBP1 mutations in myeloid neoplasms.

Authors: Hideki Makishima
Journal: Int J Hematol Date: 2017-04-26 Impact factor: 2.490

3. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.

Authors: Hélène Cavé; Aurélie Caye; Nehla Ghedira; Yline Capri; Nathalie Pouvreau; Natacha Fillot; Aurélien Trimouille; Cédric Vignal; Odile Fenneteau; Yves Alembik; Jean-Luc Alessandri; Patricia Blanchet; Odile Boute; Patrice Bouvagnet; Albert David; Anne Dieux Coeslier; Bérénice Doray; Olivier Dulac; Valérie Drouin-Garraud; Marion Gérard; Delphine Héron; Bertrand Isidor; Didier Lacombe; Stanislas Lyonnet; Laurence Perrin; Marlène Rio; Joëlle Roume; Sylvie Sauvion; Annick Toutain; Catherine Vincent-Delorme; Marjorie Willems; Clarisse Baumann; Alain Verloes
Journal: Eur J Hum Genet Date: 2016-01-13 Impact factor: 4.246

Review 4. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.

Authors: Michaela Nemcikova; Sarka Vejvalkova; Filip Fencl; Martina Sukova; Anna Krepelova
Journal: Eur J Pediatr Date: 2015-10-31 Impact factor: 3.183

5. Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).

Authors: Zhenhao Fang; Christopher B Marshall; Jiani C Yin; Mohammad T Mazhab-Jafari; Geneviève M C Gasmi-Seabrook; Matthew J Smith; Tadateru Nishikawa; Yang Xu; Benjamin G Neel; Mitsuhiko Ikura
Journal: J Biol Chem Date: 2016-05-18 Impact factor: 5.157

6. Next-generation sequencing identifies rare variants associated with Noonan syndrome.

Authors: Peng-Chieh Chen; Jiani Yin; Hui-Wen Yu; Tao Yuan; Minerva Fernandez; Christina K Yung; Quang M Trinh; Vanya D Peltekova; Jeffrey G Reid; Erica Tworog-Dube; Margaret B Morgan; Donna M Muzny; Lincoln Stein; John D McPherson; Amy E Roberts; Richard A Gibbs; Benjamin G Neel; Raju Kucherlapati
Journal: Proc Natl Acad Sci U S A Date: 2014-07-21 Impact factor: 11.205

7. Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.

Authors: Fengjuan Xu; Su'an Sun; Shilan Yan; Hongling Guo; Miao Dai; Yincheng Teng
Journal: Int J Clin Exp Pathol Date: 2015-09-01

8. The molecular functions of RIT1 and its contribution to human disease.

Authors: Richard Van; Antonio Cuevas-Navarro; Pau Castel; Frank McCormick
Journal: Biochem J Date: 2020-08-14 Impact factor: 3.857

9. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

Authors: Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Rajala; Ines Gómez-Seguí; Thomas Olson; Kathy McGraw; Bartlomiej Przychodzen; Austin Kulasekararaj; Manuel Afable; Holleh D Husseinzadeh; Naoko Hosono; Francis LeBlanc; Sonja Lagström; Dan Zhang; Pekka Ellonen; André Tichelli; Catherine Nissen; Alan E Lichtin; Aleksandra Wodnar-Filipowicz; Ghulam J Mufti; Alan F List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal: Blood Date: 2013-08-07 Impact factor: 22.113

10. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.

Authors: Wenyi Shen; Michael J Clemente; Naoko Hosono; Kenichi Yoshida; Bartlomiej Przychodzen; Tetsuichi Yoshizato; Yuichi Shiraishi; Satoru Miyano; Seishi Ogawa; Jaroslaw P Maciejewski; Hideki Makishima
Journal: J Clin Invest Date: 2014-09-17 Impact factor: 14.808